Tauromustine is a compound being used in the research of slow-release antitumor gel injections References: Gregor A, Rampling R, Aapro M, Malmstrom P, Whittle IR, Rye R, Stewart M, Sellar R, Demierre B, Ironside JW, et al. Phase II study of tauromustine in malignant glioma. Eur J Cancer. 1992;28A(12):1959-62. PubMed PMID: 1419289.

纯度：≥98%

CAS：85977-49-7